Overview

A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of trazodone hydrochloride prolonged-release tablets for treatment of depression in Chinese population.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Lee's Pharmaceutical Limited
Treatments:
Trazodone